CIK 0001533743 · <br>Emerging growth company
Processa Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PCSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 451539785
- Phone
- 443-776-3133
- Business address
- 601 21ST STREET, SUITE 300, VERO BEACH, FL, 32960
- Former names
- Heatwurx, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-31 | Ng George K Chief Executive Officer | Purchase | +2,136 | $2.54 | $5K | 3,649 |
| 2026-03-31 | Lin Patrick Chief Business - Strategy Off | Purchase | +1,603 | $2.54 | $4K | 3,356 |
| 2026-03-31 | Guy Wendy Chief Administrative Officer | Purchase | +1,854 | $2.54 | $5K | 3,110 |
| 2026-03-31 | Bigora Sian Chief Development Officer | Purchase | +2,107 | $2.54 | $5K | 3,711 |
| 2026-03-31 | Baluch Khoso Director | Purchase | +2,269 | $2.54 | $6K | 2,325 |
Page 3 of 3 · 45 trades